In simple terms, CytoTools AG has 4.966 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 1.000% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -30.361%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -29.508%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -0.023% return, is a testament to CytoTools AG's adeptness in optimizing resource deployment. CytoTools AG's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.023%. Furthermore, the proficiency of CytoTools AG in capital utilization is underscored by a remarkable -0.023% return on capital employed.
Stock Prices
CytoTools AG's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.418, while its low point bottomed out at $0.4. This variance in figures offers investors a lucid insight into the roller-coaster ride that is CytoTools AG's stock market.
Liquidity Ratios
Analyzing T5O.DE liquidity ratios reveals its financial health of the firm.
The current ratio of 2367.81% gauges short-term asset coverage for liabilities.
The quick ratio (2175.40%) assesses immediate liquidity, while the cash ratio (2175.40%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
2367.81%
Quick Ratio
2175.40%
Cash Ratio
2175.40%
Profitability Ratios
T5O.DE profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -2950.77% underscores its earnings before tax deductions.
The net income per EBT, 100.00%, and the EBT per EBIT, 97.19%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of -3036.07%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
-2950.77%
Net Income per EBT
100.00%
EBT per EBIT
97.19%
EBIT per Revenue
-3036.07%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 23.68, it details the span from stock purchase to revenue.
The 22 days it takes to settle debts showcases its creditor relations.
cards.indicator
cards.value
Days of Sales Outstanding
2175
Fixed Asset Turnover
24.95
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.08, and free cash flow per share, -0.08, depict cash generation on a per-share basis.
The cash per share value, 0.21, showcases liquidity position.
Lastly, the operating cash flow sales ratio, -25.34, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
-0.08
Free Cash Flow per Share
-0.08
Cash per Share
0.21
Operating Cash Flow Sales Ratio
-25.34
Free Cash Flow to Operating Cash Flow Ratio
1.00
Capital Expenditure Coverage Ratio
-231.49
Dividend Paid and Capex Coverage Ratio
-231.49
Per Share Data
Net income per share, -0.17, reflects the portion of profit attributed to each share.
The book value per share, 4.31, represents the net asset value distributed per share, while the tangible book value per share, 4.31, excludes intangible assets.
cards.indicator
cards.value
Net Income Per Share
-0.17
Book Value Per Share
4.31
Tangible Book Value Per Share
4.31
Shareholders Equity Per Share
4.31
Interest Debt Per Share
0.01
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -72.59%, indicates top-line expansion, while the gross profit growth, 102.47%, reveals profitability trends.
EBIT growth, 47.56%, and operating income growth, 47.56%, offer insights into operational profitability progression.
The net income growth, 79.56%, showcases bottom-line expansion, and the EPS growth, 84.16%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
-72.59%
Gross Profit Growth
102.47%
EBIT Growth
47.56%
Operating Income Growth
47.56%
Net Income Growth
79.56%
EPS Growth
84.16%
EPS Diluted Growth
84.16%
Weighted Average Shares Growth
27.54%
Weighted Average Shares Diluted Growth
27.54%
Operating Cash Flow Growth
41.68%
Free Cash Flow Growth
46.26%
10-Year Revenue Growth per Share
-91.56%
5-Year Revenue Growth per Share
-94.21%
3-Year Revenue Growth per Share
-75.17%
10-Year Operating CF Growth per Share
55.04%
5-Year Operating CF Growth per Share
66.25%
3-Year Operating CF Growth per Share
26.60%
10-Year Net Income Growth per Share
56.31%
5-Year Net Income Growth per Share
66.88%
3-Year Net Income Growth per Share
52.21%
10-Year Shareholders Equity Growth per Share
19.14%
5-Year Shareholders Equity Growth per Share
-13.62%
3-Year Shareholders Equity Growth per Share
-11.38%
3-Year Dividend per Share Growth per Share
-100.00%
Asset Growth
18.29%
Book Value per Share Growth
-6.01%
Debt Growth
-100.00%
SGA Expenses Growth
-99.35%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 3,871,176.2, captures the company's total value, considering both debt and equity.
Income quality, 1.10, assesses the reliability of reported earnings.
cards.indicator
cards.value
Enterprise Value
3,871,176.2
Income Quality
1.10
Capex to Operating Cash Flow
0.40%
Capex to Revenue
-29.46%
Capex to Depreciation
-68.66%
Graham Number
4.03
Return on Tangible Assets
-3.84%
Graham Net Net
0.34
Working Capital
1,909,393
Tangible Asset Value
21,419,074
Net Current Asset Value
1,764,573
Average Receivables
43,547.5
Average Payables
66,976.5
Average Inventory
11,276.99
Days Sales Outstanding
1328
ROIC
-4.00%
ROE
-0.04%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.12, and the price to book ratio, 0.12, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 147.20, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, -5.78, and price to operating cash flows, -6.01, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
0.12
Price to Book Ratio
0.12
Price to Sales Ratio
147.20
Price Cash Flow Ratio
-6.01
Enterprise Value Multiple
-7.05
Price Fair Value
0.12
Price to Operating Cash Flow Ratio
-6.01
Price to Free Cash Flows Ratio
-5.78
Price to Tangible Book Ratio
0.27
Enterprise Value to Sales
316.45
Enterprise Value Over EBITDA
-4.94
EV to Operating Cash Flow
-4.25
Earnings Yield
-14.53%
Free Cash Flow Yield
-16.01%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
